Does targeted therapy treat liver cancer?

Targeted medicines act on particular signals or blood-supply pathways that help cancer cells grow. They are different from treatments that affect many rapidly dividing cells. For liver cancer, the choice depends on whether the tumour began in the liver, how far it has spread, previous treatment, and how well the liver is working. A medicine may slow or control disease rather than remove every cancer cell, so treatment goals should be made explicit.

Ask the oncology team which tumour tests are relevant and whether a targeted medicine fits your diagnosis. Bring a list of medicines, supplements, liver conditions, and prior procedures. Monitoring may include blood tests for liver function, blood pressure checks, imaging, and discussion of symptoms such as diarrhoea, skin changes, tiredness, or reduced appetite. Do not stop treatment or start a supplement without advice.

Contact the treatment team promptly for yellowing of the skin or eyes, dark urine, unusual bleeding, severe abdominal swelling, persistent vomiting, confusion, or a marked change in alertness. Seek emergency help for trouble breathing, sudden weakness, fainting, or heavy bleeding. These symptoms need assessment because liver disease and treatment effects can both require rapid attention.

Which liver cancer type do I have, and what is the treatment goal? What tumour features support or argue against targeted therapy? How will you check liver function and response? Which symptoms should be reported the same day?